Skip to main content or view accessibility statement.
Published August 21, 2008
Some of our readers have contacted us with questions regarding Buprenorphine. In response to these questions, we’ve assembled some resources below.
In 2002, the FDA approved the use of Suboxone® and Subutex®—high doses of Buprenorphine in pill form—for opioid addiction. This followed the Drug Addiction Treatment Act of 2000, which allowed doctors to legally prescribe opioids to manage addiction. Opioid addiction includes dependence on heroin, oxycodone, hydrocodone, morphine, oxymorphone, and fentanyl, among others.
In the US, using medicine to manage opioid dependence is highly regulated. In order to prescribe Suboxone® and Subutex® for opioid addiction treatment, doctors must meet certain federal requirements. In addition, once doctors become approved subscribers, they are limited in the number of patients they may treat with these drugs.
For more detailed information on Buprenorphine and its use to treat addiction, please refer to the following resources:
Read the latest about PRO-ACT and recovery from addiction. Visit the PRO-ACT Journal.
See all of PRO-ACT’s scheduled events, programs, trainings, and meetings. Visit the PRO-ACT Calendar.
Learn your rights. Purchase copies of PRO-ACT’s Consumer Guides or read the full text online.
View PRO-ACT’s guide to Act 106.
We need your help! Become a member. Volunteer. Sponsor an event or otherwise Get Involved.
Learn more about PRO-ACT’s Recovery Community Centers.
See what resources are available to those in recovery. Visit PRO-ACT’s Recovery Resources.
Find your elected state officials.